The ICH Q14 guideline on Analytical procedure development will be effective from June 2024.
This guideline describes science and risk-based approaches to developing and maintaining analytical procedures suitable for assessing the quality of drug substances and drug products. This guideline complements ICH Q2 Validation of Analytical Procedures...